Research Article
Prognostic Significance of Cyclins A2, B1, D1, and E1 and CCND1 Numerical Aberrations in Oral Squamous Cell Carcinomas
Table 2
Primary antibodies used in the present study.
| Antibody | Clone | Dilution | Pretreatment | Manufacturer |
| Anti-Ki-67 | MIB-1 | 1/200 | WB + TE | DakoCytomation, Glostrup, Denmark | Anti-cyclin D1 | SP4 | Prediluted | WB | Master Diagnostica, Spain | Anti-cyclin E1 | 13A3 | 1/50 | WB | Novocastra Leica Biosystems, Newcastle upon Tyne, UK | Anti-cyclin A2 | 6E6 | 1/10 | WB | Novocastra Leica Biosystems, Newcastle upon Tyne, UK | Anti-cyclin B1 | 7A9 | 1/10 | WB | Novocastra Leica Biosystems, Newcastle upon Tyne, UK |
|
|
WB: waterbath at 98°C 30 minutes; TE: tris-ethylenediaminetetraacetic acid (EDTA).
|